MR perfusion in and around the contrast-enhancement of primary CNS lymphomas

被引:28
|
作者
Blasel, Stella [1 ]
Jurcoane, Alina [1 ]
Baehr, Oliver [2 ]
Weise, Lutz [3 ]
Harter, Patrick N. [4 ]
Hattingen, Elke [1 ]
机构
[1] Goethe Univ Frankfurt, Goethe Univ Hosp Frankfurt, Inst Neuroradiol, D-60528 Frankfurt, Germany
[2] Goethe Univ Hosp Frankfurt, Dr Senckenberg Inst Neurooncol, D-60528 Frankfurt, Germany
[3] Goethe Univ Hosp Frankfurt, Dept Neurosurg, D-60528 Frankfurt, Germany
[4] Goethe Univ Frankfurt, Edinger Inst, Inst Neurol, D-60528 Frankfurt, Germany
关键词
Primary CNS lymphoma; Tumor infiltration; MR-perfusion; rCBV; Glioblastoma; NERVOUS-SYSTEM LYMPHOMA; ENDOTHELIAL GROWTH-FACTOR; HIGH-GRADE GLIOMAS; SOLITARY METASTASES; CEREBRAL LYMPHOMAS; MALIGNANT-LYMPHOMA; MASS LESIONS; DIFFUSION; ANGIOGENESIS; EXPRESSION;
D O I
10.1007/s11060-013-1161-z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Diffuse cerebral infiltration of primary brain tumors may be missed on conventional MRI. In glioblastomas it may be visible on MR-perfusion images as an elevated rCBV adjacent to the contrast enhancing area (penumbra). We aimed to evaluate whether penumbral rCBV of primary central nervous system lymphomas (PCNSL) is also increased and if PCNSL perfusion has different features than that of glioblastomas. We measured dynamic susceptibility contrast MR-perfusion at 3 Tesla in 38 presurgical patients with histopathological diagnosis of PCNSL (n = 19) and glioblastoma (n = 19). We compared normalized rCBV within and adjacent to the enhancing area and evaluated time-signal intensity curves (TSIC) in all patients. Histopathological comparison of patients with different TSIC patterns (with or without shoulder-like increase) was performed. Relative to the normal tissue, rCBV within and adjacent to the enhancing area was increased (p < 0.05) in both glioblastomas and PCNSL. In the penumbra the increase was moderate in both groups, with 1.4 +/- A 0.46 in PCNSL and 1.82 +/- A 0.82 in glioblastomas (p = 0.07 between groups). In the enhancing tumor the increase was moderate in PCNSL (1.46 +/- 0.62) and marked in glioblastomas (4.13 +/- A 2.44) (p < 0.001 between groups). A shoulder-like TSIC increase was exclusively found in PCNSL (11/19) and was significantly associated with a less prominent reticulin fibre network compared to the PCNSL without a shoulder-like TSIC increase. The moderately increased penumbral rCBV in PCNSL and glioblastomas reveals tumor-related changes beyond the tumor borders which are invisible with conventional MRI. PCNSL can be differentiated from glioblastomas through their significantly lower rCBV and shoulder-like signal intensity changes inside the enhancing area.
引用
收藏
页码:127 / 134
页数:8
相关论文
共 50 条
  • [41] Contrast-enhancement cardiac magnetic resonance imaging beyond the scope of viability
    Olimulder, M. A. G. M.
    Galjee, M. A.
    van Es, J.
    Wagenaar, L. J.
    von Birgelen, C.
    NETHERLANDS HEART JOURNAL, 2011, 19 (05) : 236 - 245
  • [42] Analysis of first-pass and delayed contrast-enhancement patterns of dysfunctional myocardium on MR imaging: Use in the prediction of myocardial viability
    Sandstede, JJW
    Lipke, C
    Beer, M
    Harre, K
    Pabst, T
    Kenn, W
    Neubauer, S
    Hahn, D
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2000, 174 (06) : 1737 - 1740
  • [43] Usefulness of enhancement-perfusion mismatch in differentiation of CNS lymphomas from other enhancing malignant tumors of the brain
    Goyal, Pradeep
    Kumar, Yogesh
    Gupta, Nishant
    Malhotra, Ajay
    Gupta, Saurabh
    Gupta, Sonali
    Mangla, Manisha
    Mangla, Rajiv
    QUANTITATIVE IMAGING IN MEDICINE AND SURGERY, 2017, 7 (05) : 511 - 519
  • [44] New MR perfusion features in primary central nervous system lymphomas: pattern and prognostic impact
    Blasel, Stella
    Vorwerk, Rieke
    Kiyose, Makoto
    Mittelbronn, Michel
    Brunnberg, Uta
    Ackermann, Hanns
    Voss, Martin
    Harter, Patrick N.
    Hattingen, Elke
    JOURNAL OF NEUROLOGY, 2018, 265 (03) : 647 - 658
  • [45] Extending the resection beyond the contrast-enhancement for glioblastoma: feasibility, efficacy, and outcomes
    Mampre, David
    Ehresman, Jeffrey
    Pinilla-Monsalve, Gabriel
    Osorio, Maria Alejandra Gamboa
    Olivi, Alessandro
    Quinones-Hinojosa, Alfredo
    Chaichana, Kaisorn L.
    BRITISH JOURNAL OF NEUROSURGERY, 2018, 32 (05) : 528 - 535
  • [46] New MR perfusion features in primary central nervous system lymphomas: pattern and prognostic impact
    Stella Blasel
    Rieke Vorwerk
    Makoto Kiyose
    Michel Mittelbronn
    Uta Brunnberg
    Hanns Ackermann
    Martin Voss
    Patrick N. Harter
    Elke Hattingen
    Journal of Neurology, 2018, 265 : 647 - 658
  • [47] Current Treatment Standards of primary CNS Lymphomas
    Schorb, Elisabeth
    Illerhaus, Gerald
    Finke, Juergen
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2019, 144 (03) : 157 - 160
  • [48] MEMBRANOUS CHANGES IN PRIMARY MALIGNANT CNS LYMPHOMAS
    SLOWIK, F
    JELLINGER, K
    ACTA NEUROPATHOLOGICA, 1989, 79 (01) : 86 - 93
  • [49] VH gene analysis of primary CNS lymphomas
    Pels, H
    Montesinos-Rongen, M
    Schaller, C
    Schlegel, U
    Schmidt-Wolf, I
    Wiestler, O
    Deckert, M
    NEURO-ONCOLOGY, 2005, 7 (03) : 325 - 325
  • [50] Factor XIIIa expression in primary CNS lymphomas
    Treseler, P
    Parikh, S
    Shen, A
    Karch, J
    Shuman, M
    Rubenstein, J
    MODERN PATHOLOGY, 2005, 18 : 295A - 296A